Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3040% below fair value

$2.86−0.14 (-4.67%)

Close on Nov 13, 2026Market cap $122.83MP/E –Yield –

Pulmonx total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Pulmonx's total debt was $37.81M at Sep 30, 2026. For fiscal 2025 it was $37.10M, down 0.2% from the year before. The highest annual figure on record is $37.24M in fiscal 2023.

Annual total debt

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$37.10M	-0.2%
FY2024	Dec 31, 2024	$37.18M	-0.2%
FY2023	Dec 31, 2023	$37.24M	+115.0%
FY2022	Dec 31, 2022	$17.32M	-0.5%
FY2021	Dec 31, 2021	$17.42M	–
FY2020	Dec 31, 2020	$0	–

Quarterly total debt

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$37.81M	+1.8%
Q2 FY2026	Jun 30, 2026	$37.53M	+1.1%
Q1 FY2026	Mar 31, 2026	$37.31M	+0.3%
Q4 FY2025	Dec 31, 2025	$37.10M	-0.2%
Q3 FY2025	Sep 30, 2025	$37.13M	-0.3%
Q2 FY2025	Jun 30, 2025	$37.12M	-0.2%
Q1 FY2025	Mar 31, 2025	$37.20M	-0.1%
Q4 FY2024	Dec 31, 2024	$37.18M	-0.2%
Q3 FY2024	Sep 30, 2024	$37.24M	-0.0%
Q2 FY2024	Jun 30, 2024	$37.20M	-0.1%
Q1 FY2024	Mar 31, 2024	$37.23M	-0.1%
Q4 FY2023	Dec 31, 2023	$37.24M	+115.0%
Q3 FY2023	Sep 30, 2023	$37.25M	+114.3%
Q2 FY2023	Jun 30, 2023	$37.24M	+114.3%
Q1 FY2023	Mar 31, 2023	$37.26M	+113.8%
Q4 FY2022	Dec 31, 2022	$17.32M	-0.5%
Q3 FY2022	Sep 30, 2022	$17.38M	+425.8%
Q2 FY2022	Jun 30, 2022	$17.38M	+820.1%
Q1 FY2022	Mar 31, 2022	$17.43M	+3592.2%
Q4 FY2021	Dec 31, 2021	$17.42M	–
Q3 FY2021	Sep 30, 2021	$3.31M	–
Q2 FY2021	Jun 30, 2021	$1.89M	–
Q1 FY2021	Mar 31, 2021	$472.00K	–
Q4 FY2020	Dec 31, 2020	$0	–